BOUL — Boule Diagnostics AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Boule Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	499	400	463	548	571
Cost of Revenue
Gross Profit	226	177	199	228	250
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	429	406	427	519	532
Operating Profit	70	-5.93	36	29	39.3
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	50.6	-49	28.8	20.8	30.1
Provision for Income Taxes
Net Income After Taxes	37.5	-48	23.3	12.7	25
Net Income Before Extraordinary Items
Net Income	37.5	-48	23.3	12.7	25
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	37.5	-48	23.3	12.7	25
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.37	-1.07	0.826	0.451	0.64
Dividends per Share